Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.

Journal of genetic counseling - 1 Feb 2016

Brunstrom Kate, Murray Alexandra, McAllister Marion

Abstract excerpt

This qualitative interview study focuses on the experiences of a sample of British female BRCA 1/2 carriers who had predictive testing before the age of 30, which is the minimum age for breast screening in the UK. Following appropriate informed consent procedures participants were recruited through the Cancer Genetics Service for Wales. Semi-structured interviews were conducted face-to-face with seven...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Choice Behavior
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Health Knowledge, Attitudes, Practice

Share to Mutation

Share to Stress, Psychological

Source

Identifiers

PMID: 25983051
DOI: 10.1007/s10897-015-9845-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.PMID 25983051Read ↗

Reproductive decision-making in young female carriers of a BRCA mutation.Semantic proximity Read ↗

Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.Semantic proximity Read ↗

Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.Semantic proximity Read ↗

Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort.Semantic proximity Read ↗

Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.Semantic proximity Read ↗

A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.Semantic proximity Read ↗

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Semantic proximity Read ↗

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.Semantic proximity Read ↗

Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.Semantic proximity Read ↗

Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk.Semantic proximity Read ↗

Being young, female, and BRCA positive.Semantic proximity Read ↗

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.